...
首页> 外文期刊>BioMedical Engineering OnLine >Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy
【24h】

Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy

机译:抗血管生成治疗中肿瘤生长和微环境的多尺度数学建模

获取原文
           

摘要

Background Angiogenesis, a process of generation of new blood vessels from the pre-existing vasculature, has been demonstrated to be a basic prerequisite for sustainable growth and proliferation of tumour. Anti-angiogenic treatments show normalization of tumour vasculature and microenvironment at least transiently in both preclinical and clinical settings. Methods In this study, we proposed a multi-scale mathematical model to simulate the dynamic changes of tumour microvasculature and microenvironment in response to anti-angiogenic drug endostatin (ES). We incorporated tumour growth, angiogenesis and vessel remodelling at tissue level, by coupling tumour cell phenotypes and endothelial cell behaviour in response to local chemical and haemodynamical microenvironment. Results Computational simulation results showed the tumour morphology and growth curves in general tumour progression and following different anti-angiogenic drug strategies. Furthermore, different anti-angiogenic drug strategies were designed to test the influence of ES on tumour growth and morphology. The largest reduction of tumour size was found when ES is injected at simulation time 100, which was concomitant with the emergence of angiogenesis phase. Conclusion The proposed model not only can predict detailed information of chemicals distribution and vessel remodelling, but also has the potential to specific anti-angiogenic drugs by modifying certain functional modules.
机译:背景技术血管生成是从先前存在的脉管系统生成新血管的过程,已被证明是肿瘤可持续生长和扩散的基本前提。抗血管生成治疗显示至少在临床前和临床环境中肿瘤血管和微环境的正常化。方法在本研究中,我们提出了一个多尺度数学模型来模拟肿瘤微血管和微环境对抗血管生成药物内皮抑素(ES)的动态变化。我们通过结合肿瘤细胞表型和内皮细胞对局部化学和血液动力学微环境的反应,在组织水平上整合了肿瘤生长,血管生成和血管重塑。结果计算模拟结果显示了在一般肿瘤进展中以及遵循不同的抗血管生成药物策略的肿瘤形态和生长曲线。此外,设计了不同的抗血管生成药物策略来测试ES对肿瘤生长和形态的影响。当在模拟时间100注射ES时发现最大的肿瘤缩小,这与血管生成阶段的出现同时出现。结论所提出的模型不仅可以预测化学物质分布和血管重塑的详细信息,而且通过修改某些功能模块具有针对特定抗血管生成药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号